Possibly, imprinting heterogeneity at the DLK1-DIO3 gene cluster reflects differentiation states in neuroblastoma progenitor cells, and incomplete imprinting may characterize the cell-of-origin of more aggressive or treatment-resistant tumors. This evidence concerns the gene DLK1 and neuroblastoma.